ARTICLE | Clinical News
In October, EMA's CHMP recommended expanding the label of Pegasys peginterferon alfa-2a (RG442) from Roche (SIX:ROG; OTCQX:RHHBY) to treat hepatitis B envelope antigen (HBeAg)-positive chronic HBV infection in non-cirrhotic children and adolescents three years of age and older with evidence of viral replication and persistently elevated serum alanine aminotransferase (ALT) levels...
BCIQ Company Profiles
BCIQ Target Profiles